companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

TULANE RESTRNT HEAD OFC

CAMBRIDGE-Canada

Company Name:
Corporate Name:
TULANE RESTRNT HEAD OFC
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 907 King St E,CAMBRIDGE,ON,Canada 
ZIP Code:
Postal Code:
N3H 
Telephone Number: 5196531400 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
0 
USA SIC Description:
Apartments 
Number of Employees:
 
Sales Amount:
$500,000 to $1 million 
Credit History:
Credit Report:
Excellent 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
TURNBULL, LESLIE
TURKSTRA LUMBER CO LTD
TURKSTRA LUMBER
Next company profile:
TUGENDER DAVID M
TUBBY TIRES
TUAK DRAPERY MANUFACTURING I










Company News:
  • Could a Single Shot at Birth Shield Kids From HIV for Years?
    Tulane researchers said that’s roughly the equivalent of a treatment that could ward off HIV in humans deep into adolescence If the gene therapy was delivered even a bit later — 8 to 12 weeks after birth — the young monkey's more developed immune system swung into action to fight it, eroding its effectiveness
  • Access to Ophthalmologists Improved From 2014 to 2024
    via HealthDay MONDAY, Nov 24, 2025 -- Overall access to ophthalmologists improved from 2014 to 2024, according to a research letter published online Nov 13 in JAMA Ophthalmology Peter R Kastl, M D , Ph D , from Tulane University in New Orleans, and colleagues calculated distances patients must travel to reach an optometrist or ophthalmologist The analysis included data from the Doctors
  • Matulane Uses, Side Effects Warnings - Drugs. com
    Matulane: side effects, dosage, interactions, FAQs, reviews Used for: anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma multiforme, hodgkin's lymphoma
  • American Academy of Pediatrics, Sept. 26-30 - Drugs. com
    The annual meeting of the American Academy of Pediatrics was held this year from Sept 26 to 30 in Denver and attracted participants from around the world, incl
  • Monthly Obesity Shot, MariTide, Shows Big Weight Loss in Trial
    Weight loss among those with type 2 diabetes averaged 13 7% Dr Shauna Levy, medical director of the Tulane Bariatric Center in New Orleans, hailed the growing number of potential options for patients "It’s long been thought that obesity is an easy disease to treat, but in reality, it’s actually very difficult," she told NBC News
  • Healthy Habits Slash Genetic Dementia Risk in Adults with Type 2 . . .
    Study author Yilin Yoshida of Tulane University School of Medicine in New Orleans highlighted the overlap between diabetes and heart health “There are multiple factors associated with type 2 diabetes that contribute to an increased risk of cognitive decline and dementia
  • FDA Approves Polypill Widaplik for Hypertension - Drugs. com
    "I am very excited and pleased to have Widaplik approved for the treatment of hypertension in the U S Single-pill combination antihypertensive therapy has great potential to improve hypertension control in the U S and worldwide," Paul Whelton, M D , of Tulane University in New Orleans and past president of the World Hypertension League, said
  • FDA Approves Widaplik (telmisartan, amlodipine and indapamide) for the . . .
    FDA approves Widaplik (telmisartan, amlodipine, indapamide) for adults with hypertension, including as initial therapy, to help lower blood pressure




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer